China’s Strategic Positioning between BRICS and the G7: A Comparative Analysis of Multilateral Institutions
Общество: политика, экономика, право · 17.06.2026 · (5) · 67-72
DOI: 10.24158/pep.2026.5.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Общество: политика, экономика, право, online erschienen am 17.06.2026. Verfasst von Dierbai Bagezuoer.
Abstract (Originalsprache)
This article analyzes China’s strategic positioning vis-à-vis BRICS and the G7. Contrary to the binary framing of the question of “choosing between camps,” the author proceeds from the premise that China is a member of BRICS and not a member of the G7. Therefore, the issue is not one of choosing membership, but of managing participation in these institutions. A comparative institutional analysis across three parameters demonstrates that Beijing is pursuing a two-track strategy: deepening cooperation within BRICS and selective engagement with the G7 on functional issues (climate, healthcare, debt). The theoretical novelty lies in the concept of a nor-mative arbitrage strategy. The empirical basis is comprised of documents from the 2023–2025 summits, IMF data, and case studies. The key conclusion: China avoids harsh confrontation with the West, but its hybrid mod-el carries the risk of eroding trust on both sides.
Zitieren
APA
Bagezuoer, D. (2026). China’s Strategic Positioning between BRICS and the G7: A Comparative Analysis of Multilateral Institutions. Общество: политика, экономика, право, 67-72. https://doi.org/10.24158/pep.2026.5.8
Vancouver
Bagezuoer D. China’s Strategic Positioning between BRICS and the G7: A Comparative Analysis of Multilateral Institutions. Общество: политика, экономика, право. 2026:67-72. doi:10.24158/pep.2026.5.8
BibTeX
@article{Bagezuoer2026,
author = {Bagezuoer, Dierbai},
title = {China’s Strategic Positioning between BRICS and the G7: A Comparative Analysis of Multilateral Institutions},
journal = {Общество: политика, экономика, право},
year = {2026},
number = {5},
pages = {67--72},
doi = {10.24158/pep.2026.5.8}
}
EUVIMED